CABALETTA BIO, INC. Public Float
CABALETTA BIO, INC. (CABA) had Public Float of $137.00 million as of 2025-06-30, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-23
- 2025-06-30: Entity Public Float $137.00M.
- 2024-06-30: Entity Public Float $350.00M.
- 2023-06-30: Entity Public Float $494.00M.
- 2022-06-30: Entity Public Float $29.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $137.00M 10-K · filed 2026-03-23 |
| 2024-06-30 | $350.00M 10-K · filed 2025-03-31 |
| 2023-06-30 | $494.00M 10-K · filed 2024-03-21 |
| 2022-06-30 | $29.00M 10-K · filed 2023-03-16 |
| 2021-06-30 | $205.00M 10-K · filed 2022-03-17 |
| 2020-06-30 | $214.00M 10-K · filed 2021-03-16 |
| 2020-03-20 | $144.00M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |